Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 2.02% is 40% below its 2-year average of 3.33%, near the low end of its 2-year range (2.01%–4.36%).
As of the fiscal period ended Tuesday, June 30, 2026. 36.18% below its 12-month average of 3.16%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.02%.
DEBT TO ASSETS RATIO
2.02%
DEBT TO ASSETS RATIO AVG TTM
3.16%
DEBT TO ASSETS RATIO AVG 3Y
N/A
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-36.18%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 463 covered companies
CURRENT VS SECTOR MEDIAN
+1732.54%
vs the sector median at left
Aktis Oncology, Inc.
Market Cap
$989.05M
Debt to Assets Ratio
2.02%
TTM Avg
3.16%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$985.79M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.03B
Debt to Assets Ratio
0.57%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.05B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$922.50M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$921.45M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aktis Oncology, Inc. (AKTS) | $989.05M | 2.02% | 3.16% | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $985.79M | 0.01% | N/A | N/A | N/A |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | 0.57% | N/A | N/A | N/A |
| CeriBell, Inc. (CBLL)vs › | $943.26M | 0.13% | N/A | N/A | N/A |
| Immatics N.V. (IMTX)vs › | $1.04B | 0.03% | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | 0.38% | N/A | N/A | N/A |
| Arbutus Biopharma Corp (ABUS)vs › | $922.50M | 0.01% | N/A | N/A | N/A |
| HealthStream, Inc. (HSTM)vs › | $921.45M | 0.03% | N/A | N/A | N/A |
| Bioventus Inc. (BVS)vs › | $915.95M | 0.39% | N/A | N/A | N/A |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.13M | 0.00% | N/A | N/A | N/A |
Debt/Assets
2.0%
Debt/Equity
0.02
Current Ratio
16.33
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 2.02% |
| 2026-03-31 | 2.01% |
| 2025-12-31 | 4.36% |
| 2025-09-30 | 4.25% |
| 2024-12-31 | 3.68% |
| 2024-09-30 | 3.68% |
